Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Winston

Showing results (61-70 of 241) with videos related to

Pageof 25
Sort By:
AIDS Research and Therapy|April 16, 2016
Evolution of changes in cognitive function after the initiation of antiretroviral therapyBorja Mora-Peris, Elizabeth Stevens, Francesca Ferretti, et al.
The Neuroradiology Journal|October 24, 2015
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohortsShivanee Vigneswaran, Jaime H Vera Rojas, Lucy Garvey, et al.
Journal of Neurovirology|November 28, 2018
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravirMichael R Keegan, Alan Winston, Chris Higgs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Cognitive Impairment in a Clinical SettingFrancesca Ferretti, Borja Mora-Peris, Jonathan Underwood, et al.
Maturitas|January 2, 2018
Cardiovascular disease in women living with HIV: A narrative reviewDanielle Solomon, Caroline A Sabin, Patrick W G Mallon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way ForwardSam Nightingale, Anna J Dreyer, Deanna Saylor, et al.
AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.
AIDS (London, England)|July 11, 2008
An unusual abacavir reactionJulie Fox, Pippa Newton, Rosemarie Daly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 25, 2010
High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthoodYasotharan Paramesparan, Lucy J Garvey, Jane Ashby, et al.
The Journal of Infection|April 24, 2012
Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical settingTimothy Rawson, David Muir, Nicola E Mackie, et al.
Pageof 25

Showing results (61-70 of 241) with videos related to

Sort By:
Pageof 25
AIDS Research and Therapy|April 16, 2016
Evolution of changes in cognitive function after the initiation of antiretroviral therapyBorja Mora-Peris, Elizabeth Stevens, Francesca Ferretti, et al.
The Neuroradiology Journal|October 24, 2015
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohortsShivanee Vigneswaran, Jaime H Vera Rojas, Lucy Garvey, et al.
Journal of Neurovirology|November 28, 2018
Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravirMichael R Keegan, Alan Winston, Chris Higgs, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2017
Cognitive Impairment in a Clinical SettingFrancesca Ferretti, Borja Mora-Peris, Jonathan Underwood, et al.
Maturitas|January 2, 2018
Cardiovascular disease in women living with HIV: A narrative reviewDanielle Solomon, Caroline A Sabin, Patrick W G Mallon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way ForwardSam Nightingale, Anna J Dreyer, Deanna Saylor, et al.
AIDS (London, England)|August 17, 2005
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individualsAlan Winston, Gill Hales, Janaki Amin, et al.
AIDS (London, England)|July 11, 2008
An unusual abacavir reactionJulie Fox, Pippa Newton, Rosemarie Daly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 25, 2010
High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthoodYasotharan Paramesparan, Lucy J Garvey, Jane Ashby, et al.
The Journal of Infection|April 24, 2012
Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical settingTimothy Rawson, David Muir, Nicola E Mackie, et al.
Pageof 25